NCT03009734View on ClinicalTrials.gov

Evaluation of ATx201 as a Topical Antibiotic Agent

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

73

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions

Infection, Bacterial

Interventions

DRUG

ATx201 dermal formulations 2%

Topical application of ATx201 dermal formulations 2%

Trial Locations (1)

1090

Department of Clinical Pharmacology, General Hospital of Vienna, Vienna

Sponsors

Lead Sponsor

UNION therapeutics

All Listed Sponsors

lead

UNION therapeutics

INDUSTRY